Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotoxins: status and prospects.

R A Spooner1, J M Lord

  • 1Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, UK.

Trends in Biotechnology
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased quadriceps intermuscular adipose tissue in chronic liver disease is associated with an altered muscle transcriptome compared with healthy age matched controls.

GeroScience·2025
Same author

Dopamine-scrolling: a modern public health challenge requiring urgent attention.

Perspectives in public health·2025
Same author

Modelling the influence of vitamin D and probiotic supplementation on the microbiome and immune response.

Mathematical medicine and biology : a journal of the IMA·2024
Same author

Association of SARC-F Score and Rockwood Clinical Frailty Scale with CT-Derived Muscle Mass in Patients with Aortic Aneurysms.

The journal of nutrition, health & aging·2022
Same author

TANSLEY REVIEW No 3. THE STRUCTURE AND SYNTHESIS OF PLANT LECTINS.

The New phytologist·2021
Same author

Dysregulation of leukocyte trafficking in ageing: Causal factors and possible corrective therapies.

Pharmacological research·2020

Recombinant immunotoxins, combining antibodies and toxins, offer promising cancer treatments. Genetic engineering advances enable the creation of fully engineered therapeutic molecules for enhanced efficacy.

Area of Science:

  • Biotechnology
  • Oncology
  • Molecular Biology

Background:

  • Immunotoxins, conjugates of antibodies and toxins, are investigated for cancer therapy.
  • Genetic engineering presents opportunities to refine immunotoxin properties.

Purpose of the Study:

  • To explore the application of genetic engineering in developing novel immunotoxin therapies.
  • To highlight the potential of fully recombinant therapeutic molecules.

Main Methods:

  • Utilizing genetic engineering techniques to design and modify immunotoxin structures.
  • Employing recombinant DNA technology for expression and purification of therapeutic molecules.

Main Results:

  • Demonstration of the feasibility of creating completely recombinant immunotoxins.

Related Experiment Videos

  • Advancement in the design and production of targeted cancer therapeutics.

    • Conclusions:

    • Genetic engineering significantly enhances the potential of immunotoxins for cancer treatment.
    • Fully recombinant immunotoxins represent a promising frontier in targeted cancer therapy.